ミズーリ州における大腸癌の臨床試験
ミズーリ州内の拠点で、大腸癌に関する58件の研究が参加者を募集しています。
ミズーリ州内の都市
- St. Louis50件の研究
- Kansas City16件の研究
- Springfield11件の研究
- Columbia7件の研究
- Saint Joseph6件の研究
- Joplin5件の研究
- O'Fallon5件の研究
- Rolla4件の研究
- Cape Girardeau4件の研究
公式研究テキスト（英語）
The Vanguard Study: Testing a New Way to Screen for Cancer
- Saint Luke's Hospital of Kansas City, Kansas City
- Washington University School of Medicine, St Louis
被験者募集中健康なボランティア歓迎
45歳〜75歳 · 全性別 · 2026/10/05更新 · NCT06995898A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
- Washington University, St Louis
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/05更新 · NCT07659795A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
- Saint Lukes Hospital of Kansas City /ID# 279513, Kansas City
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT07525206A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- Washington University Medicine, St Louis
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06270706Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
- Washington University School of Medicine, St Louis
被験者募集中
65歳〜82歳 · 全性別 · 2026/10/02更新 · NCT05612347Family Communications After Genetic Testing
- Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
- Central Care Cancer Center - Bolivar, Bolivar
- Cox Cancer Center Branson, Branson
- 他18件
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/10/02更新 · NCT07143487Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
- MU Health - University Hospital/Ellis Fischel Cancer Center, Columbia
- Parkland Health Center - Farmington, Farmington
- Heartland Regional Medical Center, Saint Joseph
- 他6件
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT05673148Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
- Central Care Cancer Center - Bolivar, Bolivar
- Cox Cancer Center Branson, Branson
- 他21件
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- St. Lukes Hospital of Kansas City, Kansas City
- Washington University School of Medicine, St Louis
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06625775A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
- Saint Lukes Hospital of Kansas City /ID# 270633, Kansas City
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/28更新 · NCT06820463A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
- Washington University School Of Medicine, St Louis
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06750094Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- Washington University, St Louis
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/25更新 · NCT04981119Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
- Research Site, St Louis
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06218914A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
- Washington University School Of Medicine, St Louis
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06662786A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
- Local Institution - 0318, Kansas City
- Washington University School OF Medicine-Siteman Cancer Center, St Louis
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/23更新 · NCT07221357A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Washington University, St Louis
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07114601A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- Washington University School of Medicine in St. Louis, St Louis
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07213791Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Washington University, St Louis
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/16更新 · NCT05786924A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
- Missouri Cancer Associates, Columbia
- Saint Luke'S Hospital of Kansas City, Kansas City
- Midamerica Cancer Care, Kansas City
- 他2件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/15更新 · NCT07284849Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
- Washington University School of Medicine, St Louis
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/11更新 · NCT05630794Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer
- Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
- Siteman Cancer Center at West County Hospital, Creve Coeur
- Washington University School of Medicine, St Louis
- 他2件
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/09更新 · NCT06696768A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
- Washington University School of Medicine, St Louis
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/09更新 · NCT06440005A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
- Missouri Cancer Associates - 150518964, Columbia
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/09更新 · NCT07549412Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
- Clinical Study Site, Springfield
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT07228832Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Washington University School of Medicine, St Louis
被験者募集中第1/2相
12 Months – 30 Years · 全性別 · 2026/08/25更新 · NCT04851119FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Washington University School of Medicine, St Louis
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/17更新 · NCT05919264IDOV-Immune for Advanced Solid Tumors
- Washington University School of Medicine, St Louis
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/05更新 · NCT06910657Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
- University of Kansas Cancer Center - North, Kansas City
- University of Kansas Cancer Center - Lee's Summit, Lee's Summit
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/31更新 · NCT05691491A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Washington University, St Louis
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/30更新 · NCT04657068AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
- Siteman Cancer Center - Washington University, St Louis
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/30更新 · NCT07094113A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
- Washington University School of Medicine at St Louis, St Louis
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/29更新 · NCT03526835Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
- Investigative Site #110, St Louis
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/23更新 · NCT06974110A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- MidAmerica Cancer Care, Kansas City
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/22更新 · NCT06131840Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
- Washington University School of Medicine, St Louis
被験者募集中
18歳以上 · 全性別 · 2026/07/14更新 · NCT06340646CARE Tool Study Aim 3
- Delbert Day Cancer Institute at Phelps Health, Rolla
- Washington University School of Medicine, St Louis
被験者募集中
18歳以上 · 全性別 · 2026/07/08更新 · NCT07296887A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
- Midwest Oncology Associates - Kansas City, Kansas City
- SSM Health St. Louis DePaul Hospital, St Louis
- Washington University School of Medicine, St Louis
被験者募集中第4相
18歳以上 · 全性別 · 2026/07/07更新 · NCT06562543Lead-212 PSV359 Therapy for Patients With Solid Tumors
- Saint Louis University, St Louis
被験者募集中第1/2相
18歳〜90歳 · 全性別 · 2026/07/06更新 · NCT06710756Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
- Mercy Hospital - SPG, Springfield
- Mercy Hospital - South, St Louis
- Mercy Hospital -STL, St Louis
被験者募集中観察研究
18歳以上 · 全性別 · 2026/06/29更新 · NCT07327489A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- Washington University, St Louis
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/06/12更新 · NCT06051695A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
- Missouri Cancer Associates, Columbia
被験者募集中第2相
18歳以上 · 全性別 · 2026/06/12更新 · NCT07011576ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。